tetano
Editor, Senior Moderator
J Endocrinol Invest
. 2020 Oct 6.
doi: 10.1007/s40618-020-01436-w. Online ahead of print.
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis
M Rotondi[SUP] 1 2 [/SUP], F Coperchini[SUP] 1 [/SUP], G Ricci[SUP] 1 [/SUP], M Denegri[SUP] 3 [/SUP], L Croce[SUP] 1 2 [/SUP], S T Ngnitejeu[SUP] 4 [/SUP], L Villani[SUP] 5 [/SUP], F Magri[SUP] 1 2 [/SUP], F Latrofa[SUP] 6 [/SUP], L Chiovato[SUP] 7 8 [/SUP]
Affiliations
Abstract
Purpose: SARS-COV-2 is a pathogenic agent belonging to the coronavirus family, responsible for the current global world pandemic. Angiotensin-converting enzyme 2 (ACE-2) is the receptor for cellular entry of SARS-CoV-2. ACE-2 is a type I transmembrane metallo-carboxypeptidase involved in the Renin-Angiotensin pathway. By analyzing two independent databases, ACE-2 was identified in several human tissues including the thyroid. Although some cases of COVID-19-related subacute thyroiditis were recently described, direct proof for the expression of the ACE-2 mRNA in thyroid cells is still lacking. Aim of the present study was to investigate by RT-PCR whether the mRNA encoding for ACE-2 is present in human thyroid cells.
Methods: RT-PCR was performed on in vitro ex vivo study on thyroid tissue samples (15 patients undergoing thyroidectomy for benign thyroid nodules) and primary thyroid cell cultures.
Results: The ACE-2 mRNA was detected in all surgical thyroid tissue samples (n = 15). Compared with two reporter genes (GAPDH: 0.052 ? 0.0026 Cycles[SUP]-1[/SUP]; β-actin: 0.044 ? 0.0025 Cycles[SUP]-1[/SUP]; ACE-2: 0.035 ? 0.0024 Cycles[SUP]-1[/SUP]), the mean level of transcript expression for ACE-2 mRNA was abundant. The expression of ACE-2 mRNA in follicular cells was confirmed by analyzing primary cultures of thyroid cells, which expressed the ACE-2 mRNA at levels similar to tissues.
Conclusions: The results of the present study demonstrate that the mRNA encoding for the ACE-2 receptor is expressed in thyroid follicular cells, making them a potential target for SARS-COV-2 entry. Future clinical studies in patients with COVID-19 will be required for increase our understanding of the thyroid repercussions of SARS-CoV-2 infection.
Keywords: ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid.
. 2020 Oct 6.
doi: 10.1007/s40618-020-01436-w. Online ahead of print.
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis
M Rotondi[SUP] 1 2 [/SUP], F Coperchini[SUP] 1 [/SUP], G Ricci[SUP] 1 [/SUP], M Denegri[SUP] 3 [/SUP], L Croce[SUP] 1 2 [/SUP], S T Ngnitejeu[SUP] 4 [/SUP], L Villani[SUP] 5 [/SUP], F Magri[SUP] 1 2 [/SUP], F Latrofa[SUP] 6 [/SUP], L Chiovato[SUP] 7 8 [/SUP]
Affiliations
- PMID: 33025553
- DOI: 10.1007/s40618-020-01436-w
Abstract
Purpose: SARS-COV-2 is a pathogenic agent belonging to the coronavirus family, responsible for the current global world pandemic. Angiotensin-converting enzyme 2 (ACE-2) is the receptor for cellular entry of SARS-CoV-2. ACE-2 is a type I transmembrane metallo-carboxypeptidase involved in the Renin-Angiotensin pathway. By analyzing two independent databases, ACE-2 was identified in several human tissues including the thyroid. Although some cases of COVID-19-related subacute thyroiditis were recently described, direct proof for the expression of the ACE-2 mRNA in thyroid cells is still lacking. Aim of the present study was to investigate by RT-PCR whether the mRNA encoding for ACE-2 is present in human thyroid cells.
Methods: RT-PCR was performed on in vitro ex vivo study on thyroid tissue samples (15 patients undergoing thyroidectomy for benign thyroid nodules) and primary thyroid cell cultures.
Results: The ACE-2 mRNA was detected in all surgical thyroid tissue samples (n = 15). Compared with two reporter genes (GAPDH: 0.052 ? 0.0026 Cycles[SUP]-1[/SUP]; β-actin: 0.044 ? 0.0025 Cycles[SUP]-1[/SUP]; ACE-2: 0.035 ? 0.0024 Cycles[SUP]-1[/SUP]), the mean level of transcript expression for ACE-2 mRNA was abundant. The expression of ACE-2 mRNA in follicular cells was confirmed by analyzing primary cultures of thyroid cells, which expressed the ACE-2 mRNA at levels similar to tissues.
Conclusions: The results of the present study demonstrate that the mRNA encoding for the ACE-2 receptor is expressed in thyroid follicular cells, making them a potential target for SARS-COV-2 entry. Future clinical studies in patients with COVID-19 will be required for increase our understanding of the thyroid repercussions of SARS-CoV-2 infection.
Keywords: ACE-2; COVID-19; SARS-COV-2; Thyrocytes; Thyroid.